The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register
Open accessAbstract
INTRODUCTION: Studies have found that people with Multiple Sclerosis experience relatively high rates of anxiety and depression. Although methodologically robust, many of these studies had access to only modest sample sizes (N<200). The aims of this study were to use responses gained via the web portal of the UK MS Register (N>4000) to: describe the depression and anxiety profiles of people with MS; to determine if anxiety and depression are related to age or disease duration; and to assess whether the levels of anxiety and depression differ between genders and types of MS. METHODS: From its launch in May 2011 to the end of December 2011, 7786 adults with MS enrolled to take part in the UK MS Register via the web portal. The responses to the Hospital Anxiety and Depression Scale (HADS) were collated with basic demographic and descriptive MS data provided at registration and the resulting dataset was analysed in SPSS (v.16). RESULTS: The mean HADS score among the 4178 respondents was 15.7 (SE 0.117, SD 7.55) with a median of 15.0 (IQR 11). Anxiety and depression rates were notably high, with over half (54.1%) scoring ≥ 8 for anxiety and 46.9% scoring ≥ 8 for depression. Women with relapsing-remitting MS were more anxious than men with this type (p<0.001), and than women with other types of MS (p = 0.017). Within each gender, men and women with secondary progressive MS were more depressed than men or women with other types of MS (p<0.001, p<0.001). CONCLUSIONS: This largest known study of its kind has shown that anxiety and depression are highly prevalent in people with MS, indicating that their mental health needs could be better addressed. These findings support service planning and further research to provide the best care for people with MS to help alleviate these debilitating conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Jones et al. (58) studied the responses of 4178 people with MS on the MS UK register and found that people with SPMS were significantly more likely to be depressed than those with other types of MS.”
From Key demographics and psychological skills associated with adjustment to progressive Multiple Sclerosis early in the diagnosis (2022) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
The Hospital Anxiety And Depression Scale.
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-29 · Cited by 2,391
The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure
Hobart, J. (2001) · Brain · doi:10.1093/brain/124.5.962 · Cited by 1,144
A Gender Gap in Autoimmunity: Task Force on Gender, Multiple Sclerosis and Autoimmunity
Whitacre, C. C., Reingold, S. C., O'Looney, P. A., Blankenhorn, E., Brinley, F., Collier, E., Duquette, P., Fox, H., Giesser, B., Gilmore, W., et al. (1999) · Science · doi:10.1126/science.283.5406.1277 · Cited by 851
Normative data for the HADS from a large non-clinical sample
Crawford, J. R., Henry, J. D., Crombie, C., & Taylor, E. P. (2001) · British Journal of Clinical Psychology · doi:10.1348/014466501163904 · Cited by 815 · cited 3×
“There was a positive correlation between anxiety scores and depression scores indicating that the two conditions are related, and this was also seen in the general population reference group [17].”
BackgroundResultDepression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
British Journal of Clinical Psychology
(2010) · British Journal of Clinical Psychology · doi:10.1111/(issn)2044-8260 · Cited by 702
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–189 of 189
Relative contribution of cognitive and physical disability components to quality of life in MS
Schependom, J. V., D'hooghe, M. B., Schepper, M. D., Cleynhens, K., D’hooge, M., Haelewyck, M.-C., Keyser, J. D., & Nagels, G. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.020 · Cited by 10
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations
Stahmann, A., Craig, E. M., Ellenberger, D., Fneish, F., Frahm, N., Marrie, R. A., Middleton, R., Nicholas, R. S., Rodgers, J., Warnke, C., et al. (2024) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864241233044 · Cited by 10
Neuropsychiatric Status of Patients With Multiple Sclerosis Across Disease Duration Intervals
Freedman, D., Oh, J., & Feinstein, A. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20220124 · Cited by 15
Al-Hussain, F., Al-Salloum, N., Alazwary, N., Saeedi, J., Howaidi, S., & Daif, A. (2017) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0087 · Cited by 9
Psychotherapie in der neurologischen Rehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-104525 · Cited by 9
“MS 4,8–46,9 [13, 14] 8,7–54,1 [14, 15] Schizoph.”
Mancuso, M. E., Biasoli, C., Marino, R., Buzzi, A., Preti, D., Sannino, L., Tempre, R., Bendinelli, S., Pompeo, E., Siri, G., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113036 · Cited by 8
“The absence or functional deficiency of FVIII leads to bleeding tendency [3], reduced bone mineral density [4–6], and causes prolonged bleeding after trauma [3].”
BackgroundDepression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
Baldt, J., Frahm, N., Hecker, M., Streckenbach, B., Langhorst, S. E., Mashhadiakbar, P., Burian, K., Meißner, J., Heidler, F., Richter, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165379 · Cited by 11
“In a study with more than 7000 MS patients from the United Kingdom, female patients with RRMS were more likely to report higher levels of anxiety than female patients with PPMS or SPMS, whereas no significant association between anxiety and MS course type was found for men [62].”
BackgroundBahathig, A. M., Alblowi, M. A., Alhilali, A. A., AlJasim, B. S., Alhelow, M., Aldakheel, H., Alodayani, N., & Hikri, N. (2020) · Cureus · doi:10.7759/cureus.12389 · Cited by 8
“This view was the opposite of that in a study published in 2012 [20], indicating that female patients with relapsing remitting MS were more anxious than males with this type of MS, and that a female with other types of MS and secondary progressive MS patients were more depressed than other types of MS patients, regard…”
BackgroundResultInfluentialRodgers, S., Calabrese, P., Ajdacic‐Gross, V., Steinemann, N., Kaufmann, M., Salmen, A., Manjaly, Z., Kesselring, J., Kamm, C. P., Kühle, J., et al. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110402 · Cited by 8
Maguire, R., McKeague, B., Kóka, N., Coffey, L., Maguire, P., & Desmond, D. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103293 · Cited by 9
Gillanders, S., & Gillanders, D. T. (2018) · Routledge eBooks · doi:10.4324/9780429466618-3 · Cited by 8
Safi, S. Z. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs340 · Cited by 8
“Previous studies have indicated that depression is prevalent in MS patients and affects treatment adherence and is associated with neurological damage that results from MS (24-42).”
BackgroundEnsari, I., Pilutti, L. A., & Motl, R. W. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12748 · Cited by 9
Self-reported quality of life of patients with multiple sclerosis with mild disability
Shalash, A., Effat, S. M. A., Azzam, H., Elkatan, S., & Elrassas, H. H. (2016) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.4103/1110-1083.193066 · Cited by 8
Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study
Freedman, D., Oh, J., Einstein, G., & Feinstein, A. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13116-x · Cited by 9
“Although most studies fail to find a link between chronological age and depression [8, 13, 14, 16–19, 22– 25], a few report a An additional limitation of the existing literature is that most studies examine how age influences one [10, 15, 20, 22, 23, 26, 28–37], two [8, 13, 17–19, 21, 24, 25, 38,…”
InfluentialOutcome measures for multiple sclerosis
Osborne, L. A., Noble, J. G., Maramba, I. D. C., Jones, K. H., Middleton, R., Lyons, R. A., Ford, D. V., & Reed, P. (2013) · Physical Therapy Reviews · doi:10.1179/1743288x13y.0000000094 · Cited by 7
Graziano, F., Calandri, E., Borghi, M., & Bonino, S. (2019) · Women & Health · doi:10.1080/03630242.2019.1626789 · Cited by 7
“In particular, some research found a better adjustment for younger patients (Jones et al. 2012), whereas other reported greater subjective well-being for older patients (Stern et al.”
BackgroundInfluentialBehavioral disorders in multiple sclerosis: a comprehensive review
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02816-9 · Cited by 6
Zhang, H., Wang, R., Kong, Z., Yu, J., Hou, X., & Zhang, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1225356 · Cited by 7
Fleming, K. M., Coote, S. B., & Herring, M. P. (2020) · Mental health and physical activity · doi:10.1016/j.mhpa.2020.100341 · Cited by 6
Meek, C., Moghaddam, N. G., Evangelou, N., Oates, L. L., Topcu, G., Allen, C. M., & das Nair, R. (2021) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2021.07.001 · Cited by 9
“, 2017), with progressive forms most severely affected (Jones et al., 2012).”
BackgroundBogosian, A., Day, F., Norton, S., Silber, E., Sakel, M., Sharrack, B., & Moss-Morris, R. (2022) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2022.966133 · Cited by 5
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis
Nyári, A., Kokas, Z., Szamosi, S., Fricska‐Nagy, Z., Kincses, Z. T., Füvesi, J., Biernacki, T., Klivènyi, P., Bencsik, K., & Sandi, D. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07737-9 · Cited by 6
Buono, V. L., Corallo, F., Bonanno, L., Pria, D., Cara, M. D., Palmeri, R., D’Aleo, G., Rifici, C., Sessa, E., Marino, S., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105051 · Cited by 4
Knowles, L. M., Tingey, J. L., Newman, A. K., von Geldern, G., & Alschuler, K. N. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103918 · Cited by 4
Depression and Multiple Sclerosis: Clinical Aspects, Epidemiology, and Management
Théaudin, M., & Feinstein, A. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_2 · Cited by 4
Depression during multiple sclerosis relapse: relation to disability and relapse severity
Šabanagić-Hajrić, S., Suljić, E., & Sulejmanpasic-Arslanagic, G. (2015) · Medicinski Glasnik · doi:10.17392/839-16 · Cited by 4
“lated with depression, which is similar to the results from the study that investigated depression in MS patients (21).”
BackgroundResultFleming, K. M., Herring, M. P., Coote, S. B., & Tindall, D. W. S. (2021) · Disability and Rehabilitation · doi:10.1080/09638288.2021.1939446 · Cited by 4
Feinstein, A., Amato, M. P., Brichetto, G., Chataway, J., Chiaravalloti, N. D., Cutter, G., Dalgas, U., DeLuca, J., Farrell, R. A., Feys, P., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11295-5 · Cited by 4
“In addition, data from over 4000 people in the UK MS Registry show that the highest rates of depression are in people with SPMS, irrespective of gender [34].”
Psychotherapy in Neurorehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Neurology International Open · doi:10.1055/s-0043-104643 · Cited by 5
Göçmen, A., & Ethemoğlu, Ö. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107888 · Cited by 4
Psychiatric Comorbidities of Multiple Sclerosis: A Cross-Sectional Study
Fatheddine, M., Elfahiri, F. Z., Ennaciri, Z., Adali, I., & Manoudi, F. (2024) · SAS Journal of Medicine · doi:10.36347/sasjm.2024.v10i06.003 · Cited by 3
Fakorede, S., Peters, J., Murphy, T., Troung, E., & Abou, L. (2025) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2025.2518261 · Cited by 3
“This variability may be influenced by differences in MS types, as anxiety levels have been shown to vary between MS subtypes, with women with relapsing-remitting MS reporting higher anxiety than men with the same type or women with other MS types (Jones et al, 2012).”
Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment
Waskowiak, P. T., de Jong, B. A., Uitdehaag, B. M. J., Myronenko, A., Hulst, H. E., & Klein, M. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13486-2 · Cited by 3
“This may be partly due to the relatively low average HADS scores in our sample, which were lower than those reported in previous MS samples [44].”
Do Depressive Symptoms Influence Cognitive-Motor Coupling in Multiple Sclerosis?
Ensari, I., Balto, J. M., Hubbard, E., Pilutti, L., & Motl, R. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000202 · Cited by 3
“Elevated depressive symptoms in MS have been reported to be anywhere from 20% (Patten, Beck, Williams, Barbui, & Metz, 2003) to as high as 40% to 50% in large epidemiological studies (Buyukdura, McClintock, & Croarkin, 2011; Chwastiak et al., 2002; Jones et al., 2012;).”
BackgroundMethodInfluentialŠilić, P., Jeng, B., Jones, C. D., Huynh, T. L. T., Duffecy, J. L., & Motl, R. W. (2023) · Mental health and physical activity · doi:10.1016/j.mhpa.2023.100541 · Cited by 3
Exercise and Multiple Sclerosis
Motl, R. W., Cederberg, K. L. J., & Sandroff, B. M. (2020) · doi:10.1002/9781119568124.ch41 · Cited by 3
Bahmani, B., Mehraban, S., Azkhosh, M., Khanjani, M. S., & Azimian, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs-127590 · Cited by 2
Yu, M., Neate, S. L., Simpson, S., Davenport, R. A., Bevens, W., Jelinek, G. A., & Reece, J. C. (2025) · JMIR Human Factors · doi:10.2196/59363 · Cited by 2
“The 14-item Hospital Anxiety and Depression Scale was used to assess anxiety and depressive symptoms [29,30].”
Physiotherapy management of multiple sclerosis
Learmonth, Y. C. (2025) · Journal of physiotherapy · doi:10.1016/j.jphys.2025.11.008 · Cited by 2
Davis, B. E., Honomichl, R. D., & Sullivan, A. B. (2022) · International Journal of MS Care · doi:10.7224/1537-2073.2020-116 · Cited by 2
Learmonth, Y. C., Hawkins, M., Karahalios, A., Skeffington, P., Wood, E. J., & Marck, C. H. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106709 · Cited by 2
Gainotti, G., Quaranta, D., & Marra, C. (2016) · Journal of Traumatic Stress Disorders & Treatment · doi:10.4172/2324-8947.1000157 · Cited by 4
Depression and Anxiety in Patients With Multiple Sclerosis: A Systematic Review
Saadat, S., Vaghari, M., Hoodinshad, S., Isanazar, A., & Hosseininezhad, M. (2021) · Iranian Journal of Neurosurgery · doi:10.32598/irjns.7.4.1 · Cited by 1
“Furthermore, employment status influenced the severity of anxiety and depression in these patients [42].”
BackgroundSafi, S. Z. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.340 · Cited by 2
Manifestations of Post-COVID Syndrome in Healthcare Workers in Northeast England
Raw, R. K., Rees, J. C., Wilson, D., Gowans, S., Ng, C. E., & Chadwick, D. R. (2025) · COVID · doi:10.3390/covid5060091 · Cited by 1
Alaboson, J., Coffey, L., & Maguire, R. (2026) · Journal of Health Psychology · doi:10.1177/13591053251392873 · Cited by 1
“This includes an increased risk of anxiety and depression (Jones et al., 2012), with studies estimating that at least one in five PwMS experience these states (Boeschoten et al., 2017; Marrie et al., 2015).”
The mood–immunity relationship in multiple sclerosis
Ristori, G., Annibali, V., & Salvetti, M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.030 · Cited by 1
“…a plethora of literature pointing out that anxiety and depression are among the most common symptoms in MS compared to other chronic illnesses (Jones et al., 2012; Siegert and Abernethy, 2005; Villani et al., 2012), mood disorders in MS remain unrecognized, under-diagnosed and undertreated…”
BackgroundMultiple Sclerosis, Gender, and Disorders of Behavior
Feinstein, A., & Pavisian, B. (2017) · Springer eBooks · doi:10.1007/978-3-7091-4858-7_9 · Cited by 1
Bassett, V., & Hebron, C. (2023) · Disability and Rehabilitation · doi:10.1080/09638288.2023.2252329 · Cited by 1
“…experience beyond that of their Ms. Regular use of mood-related medication was noted as the researcher acknowledged it could influence exertional experience, however it was not deemed to be an exclusion criterion due to the recognised high prevalence of anxiety and depression in plwMs [40].”
Astrocyte Activation and Drug Target in Pathophysiology of Multiple Sclerosis
Bisht, P., Rathore, C., Rathee, A., & Kabra, A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_30 · Cited by 1
Effects of a Single Bout of Aquatic Exercise on Mood in Multiple Sclerosis
Genova, H. M., Dacosta‐Aguayo, R., Goverover, Y., Smith, A. D., Bober, C., & DeLuca, J. (2019) · International Journal of MS Care · doi:10.7224/1537-2073.2018-079 · Cited by 1
Lynass, R., & Gillon, E. (2017) · Counselling Psychology Review · doi:10.53841/bpscpr.2017.32.4.49 · Cited by 1
Multiple Sclerosis, Walking, and Depression
Ensari, I., & Motl, R. W. (2020) · The Wiley Encyclopedia of Health Psychology · doi:10.1002/9781119057840.ch148 · Cited by 1
Drug Treatment of Psychiatric Symptoms Occurring in the Context of Other Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg010 · Cited by 1
Incidence of Anxiety in Patients with Multiple Sclerosis (MS)
Green, R. R., Kalina, J. T., & Pandey, K. S. (2015) · Journal of Intellectual Disability - Diagnosis and Treatment · doi:10.6000/2292-2598.2015.03.02.6
“Most studies seem to have found a positive correlation between anxiety and depression in MS populations [13, 18].”
BackgroundMethodResultInfluentialCerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression
Hagens, M. H. J., Hoogervorst, E. L. J., Frequin, S. T. F. M., & Tromp, S. C. (2013) · Interventional Neurology · doi:10.1159/000363070
Multiple Sclerosis and Other Demyelinating Disorders
Arnett, P. A., & Cadden, M. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397045-9.00127-0
Ness, A. R. (2017) · MOspace Institutional Repository (University of Missouri)
The Role of Metacognition in Emotional Distress in People with Multiple Sclerosis
Heffer-Rahn, P. (2017) · University of Liverpool · doi:10.17638/03009731
Decision making under risk in multiple sclerosis
Radomski, A. D. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3bg2hh5w
Mindfulness and Multiple Sclerosis
Sadhir, M. (2018) · UKnowledge (University of Kentucky)
Tóth, E. M. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10259
Safi, S. Z. (2020) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/intechopen.86288
Lexique des troubles cognitifs dans la sclérose en plaques
Brochet, B., Clavelou, P., Seze, J. D., Defer, G. L., Delabrousse-Mayoux, J. P., Heinzlef, O., Lebrun‐Frénay, C., Magnin, É., Ruet, A., Péré, J.-J., et al. (2020) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2020.05.001
Miller, M. (2020) · Brock University Digital Repository (Brock University)
Marchant, A. L. (2020) · Cronfa (Swansea University) · doi:10.23889/suthesis.56821
Neuropsychiatric Symptoms in Demyelination Disorders
Axelerad, A. D., Axelerad, S. D., & Stroe, A. Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95618
Heinzlef, O. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_6
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Research Square · doi:10.21203/rs.3.rs-537085/v1
Alhlayl, A. S., Alzghaibi, H., & Jamal, Q. M. S. (2022) · Healthcare · doi:10.3390/healthcare10122421
“a result of unifying such information from the three different resources, the UK MS Register is pioneering in providing chances to study MS related topics in linked information [5].”
BackgroundMethodResultInfluentialArnett, P. A., & Cadden, M. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91497-0.00234-4
Rudroff, T., & Workman, C. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00026-x
Psychiatrie et sclérose en plaques : l’œuf ou la poule ?
Heinzlef, O. (2025) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2025.01.012
Anxiety, depression and cognitive impairment in people with multiple sclerosis (MS)
Cojocaru, A., & Bubuioc, L. (2025) · Vector European · doi:10.52507/2345-1106.2025-1.28
Özdoğar, A. T., Aldemir, E., Yeşiloğlu, P., & Çilingir, V. (2025) · Ege Tıp Dergisi · doi:10.19161/etd.1632949
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960222
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960219
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960216
Smyth, P. S., Watson, K. E., & Tsuyuki, R. T. (2021) · Figshare · doi:10.6084/m9.figshare.16960213
Exploring predictors of anxiety in patients with relapsing-remitting multiple sclerosis
Poprelka, K., Fasilis, T., Patrikelis, P., Stefanatou, M., Ntinopoulou, E., Verentzioti, A., Alexoudi, A., Stavrinou, L. C., Korfias, S. I., & Gatzonis, S. D. (2026) · Journal of Health Psychology · doi:10.1177/13591053261416350
“Relapsing-remitting disease course, higher levels of fatigue, alexithymia, disability, duration of the disease, and pain have been associated with anxiety levels in pwMS (Beiske et al., 2008; Chahraoui et al., 2014; Janssens et al., 2003; Jones et al., 2012; Podda et al., 2020; Zhang et al., 2023).”
Pagliari, C., Cabinio, M., & Blasi, V. (2026) · Springer eBooks · doi:10.1007/978-3-032-08980-9_21
Bazmi, E., Behnoush, A. H., Lapevandani, M. M., Talebian, M. T., Jahani, S., & Sahraian, M. A. (2026) · Health Science Reports · doi:10.1002/hsr2.72331
“Moreover, depressive symptoms tend to be more severe in individuals with MS [57–59].”
Galindo, J., & Copeland, C. T. (2026) · Springer eBooks · doi:10.1007/978-3-032-07777-6_22
Abbas, S., Chebly, A., Harb, F., Salameh, R., Azar, A., Hanna, C., Ibrahim, A., & Khalil, C. (2026) · Journal of Regenerative Medicine and Biology Research · doi:10.46889/jrmbr.2026.7110
Metadata
- Authors
- Jones, K. H., Ford, D. V., Jones, P. A., John, A., Middleton, R. M., Lockhart-Jones, H., Osborne, L. A., & Noble, J. G.
- Affiliations
- Swansea University (GB)
- Corresponding author
- Jones, Kerina H.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-07-30
- Volume
- 7
- Issue
- 7
- Pages
- e41910
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3408498
- OpenAlex
- W1964142942
- Cited by
- 190
- References
- 33
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 10 · 2023: 12 · 2022: 14 · 2021: 19 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 16 · 2016: 14 · 2015: 22 · 2014: 14 · 2013: 9 · 2012: 3
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, anxiety, depression, prevalence, gender differences, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, disease duration, age, mental health, Hospital Anxiety and Depression Scale
- MeSH terms
- Adolescent, Adult, Aged, Anxiety, Depression, Female, United Kingdom, Health Surveys, Humans, Male, Middle Aged, Multiple Sclerosis, Prevalence, Statistics, Nonparametric, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
